But they say that despite these limitations, patients and providers should consider the potential for serious adverse cardiac effects of treatment with rosiglitazone.

• 但他们说，尽管有这些限制，病人和供者应考虑到用罗格列酮治疗中潜在的严重不良的心脏治疗。